Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

Tekijä Swift, Stephanie L., Stojdl, David F.
Julkaisussa Viruses (2016)

High-throughput screening to enhance oncolytic virus immunotherapy

Tekijä Allan, KJ, Stojdl, David F, Swift, SL
Julkaisussa Oncolytic Virother (2016)

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Tekijä Allan, Kristina J., Mahoney, Douglas J., Baird, Stephen D., Lefebvre, Charles A., Stojdl, David F.
Julkaisussa J Vis Exp (2018)

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

Tekijä Hassanzadeh, Golnoush, Naing, Thet, Graber, Tyson, Jafarnejad, Seyed Mehdi, Stojdl, David F., Alain, Tommy, Holcik, Martin
Julkaisussa Int J Mol Sci (2019)

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain

Tekijä Balathasan, Lukxmi, Tang, Vera A., Yadollahi, Beta, Brun, Jan, Labelle, Melanie, Lefebvre, Charles, Swift, Stephanie L., Stojdl, David F.
Julkaisussa Mol Ther Oncolytics (2017)

The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus

Tekijä Stojdl, David F., Abraham, Ninan, Knowles, Shane, Marius, Ricardo, Brasey, Ann, Lichty, Brian D., Brown, Earl G., Sonenberg, Nahum, Bell, John C.
Julkaistu 2000

Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis

Tekijä Ben Yebdri, Fethia, Van Grevenynghe, Julien, Tang, Vera A, Goulet, Marie-Line, Wu, Jian Hui, Stojdl, David F, Hiscott, John, Lin, Rongtuan
Julkaistu 2013

Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus

Tekijä Brun, Jan, McManus, Dan, Lefebvre, Charles, Hu, Kang, Falls, Theresa, Atkins, Harold, Bell, John C, McCart, J. Andrea, Mahoney, Douglas, Stojdl, David F
Julkaistu 2010

Maraba Virus as a Potent Oncolytic Vaccine Vector

Tekijä Pol, Jonathan G, Zhang, Liang, Bridle, Byram W, Stephenson, Kyle B, Rességuier, Julien, Hanson, Stephen, Chen, Lan, Kazdhan, Natasha, Bramson, Jonathan L, Stojdl, David F, Wan, Yonghong, Lichty, Brian D
Julkaistu 2014

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

Tekijä Dobson, Christine C, Naing, Thet, Beug, Shawn T, Faye, Mame D, Chabot, Janelle, St-Jean, Martin, Walker, Danielle E, LaCasse, Eric C, Stojdl, David F, Korneluk, Robert G, Holcik, Martin
Julkaisussa Oncotarget (2016)

Development and applications of oncolytic Maraba virus vaccines

Tekijä Pol, Jonathan G, Atherton, Matthew J, Bridle, Byram W, Stephenson, Kyle B, Le Boeuf, Fabrice, Hummel, Jeff L, Martin, Chantal G, Pomoransky, Julia, Breitbach, Caroline J, Diallo, Jean-Simon, Stojdl, David F, Bell, John C, Wan, Yonghong, Lichty, Brian D
Julkaisussa Oncolytic Virother (2018)

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Tekijä Nguyên, Thi Lien-Anh, Abdelbary, Hesham, Arguello, Meztli, Breitbach, Caroline, Leveille, Simon, Diallo, Jean-Simon, Yasmeen, Amber, Bismar, Tarek A., Kirn, David, Falls, Theresa, Snoulten, Valerie E., Vanderhyden, Barbara C., Werier, Joel, Atkins, Harold, Vähä-Koskela, Markus J. V., Stojdl, David F., Bell, John C., Hiscott, John
Julkaistu 2008

Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease

Tekijä Zhang, Jiqing, Tai, Lee-Hwa, Ilkow, Carolina S, Alkayyal, Almohanad A, Ananth, Abhirami A, de Souza, Christiano Tanese, Wang, Jiahu, Sahi, Shalini, Ly, Lundi, Lefebvre, Charles, Falls, Theresa J, Stephenson, Kyle B, Mahmoud, Ahmad B, Makrigiannis, Andrew P, Lichty, Brian D, Bell, John C, Stojdl, David F, Auer, Rebecca C
Julkaistu 2014

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

Tekijä Evgin, Laura, Ilkow, Carolina S, Bourgeois-Daigneault, Marie-Claude, de Souza, Christiano Tanese, Stubbert, Lawton, Huh, Michael S, Jennings, Victoria A, Marguerie, Monique, Acuna, Sergio A, Keller, Brian A, Lefebvre, Charles, Falls, Theresa, Le Boeuf, Fabrice, Auer, Rebecca A, Lambris, John D, McCart, J Andrea, Stojdl, David F, Bell, John C
Julkaisussa Mol Ther Oncolytics (2016)

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Tekijä Atherton, Matthew J., Stephenson, Kyle B., Tzelepis, Fanny, Bakhshinyan, David, Nikota, Jake K., Son, Hwan Hee, Jirovec, Anna, Lefebvre, Charles, Dvorkin-Gheva, Anna, Ashkar, Ali A., Wan, Yonghong, Stojdl, David F., Belanger, Eric C., Breau, Rodney H., Bell, John C., Saad, Fred, Singh, Sheila K., Diallo, Jean-Simone, Lichty, Brian D.
Julkaisussa Oncoimmunology (2018)

Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine

Tekijä Lemay, Chantal G, Rintoul, Julia L, Kus, Agnieszka, Paterson, Jennifer M, Garcia, Vanessa, Falls, Theresa J, Ferreira, Lisa, Bridle, Byram W, Conrad, David P, Tang, Vera A, Diallo, Jean-Simon, Arulanandam, Rozanne, Le Boeuf, Fabrice, Garson, Kenneth, Vanderhyden, Barbara C, Stojdl, David F, Lichty, Brian D, Atkins, Harold L, Parato, Kelley A, Bell, John C, Auer, Rebecca C
Julkaistu 2012

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

Tekijä Pol, Jonathan G., Acuna, Sergio A., Yadollahi, Beta, Tang, Nan, Stephenson, Kyle B., Atherton, Matthew J., Hanwell, David, El-Warrak, Alexander, Goldstein, Alyssa, Moloo, Badru, Turner, Patricia V., Lopez, Roberto, LaFrance, Sandra, Evelegh, Carole, Denisova, Galina, Parsons, Robin, Millar, Jamie, Stoll, Gautier, Martin, Chantal G., Pomoransky, Julia, Breitbach, Caroline J., Bramson, Jonathan L., Bell, John C., Wan, Yonghong, Stojdl, David F., Lichty, Brian D., McCart, J. Andrea
Julkaisussa Oncoimmunology (2018)